CN111551658A - Rapid detection and analysis method of antihistamines in water - Google Patents
Rapid detection and analysis method of antihistamines in water Download PDFInfo
- Publication number
- CN111551658A CN111551658A CN202010385171.6A CN202010385171A CN111551658A CN 111551658 A CN111551658 A CN 111551658A CN 202010385171 A CN202010385171 A CN 202010385171A CN 111551658 A CN111551658 A CN 111551658A
- Authority
- CN
- China
- Prior art keywords
- water
- sample
- detection
- antihistamines
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 238000001514 detection method Methods 0.000 title claims abstract description 39
- 239000000739 antihistaminic agent Substances 0.000 title claims abstract description 28
- 229940125715 antihistaminic agent Drugs 0.000 title claims abstract description 27
- 238000004458 analytical method Methods 0.000 title claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 36
- 238000002414 normal-phase solid-phase extraction Methods 0.000 claims abstract description 16
- 239000007788 liquid Substances 0.000 claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960001803 cetirizine Drugs 0.000 claims abstract description 6
- SOYKEARSMXGVTM-UHFFFAOYSA-N chlorphenamine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 SOYKEARSMXGVTM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003291 chlorphenamine Drugs 0.000 claims abstract description 6
- 229960001380 cimetidine Drugs 0.000 claims abstract description 6
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 claims abstract description 6
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960000520 diphenhydramine Drugs 0.000 claims abstract description 6
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960003592 fexofenadine Drugs 0.000 claims abstract description 6
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 claims abstract description 6
- 229960000620 ranitidine Drugs 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 24
- 239000007789 gas Substances 0.000 claims description 16
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 13
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 12
- ADCGAPKUMAQOLJ-UHFFFAOYSA-N azane;formic acid Chemical compound N.OC=O.OC=O ADCGAPKUMAQOLJ-UHFFFAOYSA-N 0.000 claims description 12
- 235000019253 formic acid Nutrition 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 8
- 238000010813 internal standard method Methods 0.000 claims description 6
- 238000000746 purification Methods 0.000 claims description 6
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 6
- 239000012498 ultrapure water Substances 0.000 claims description 6
- 239000003344 environmental pollutant Substances 0.000 claims description 5
- 239000012071 phase Substances 0.000 claims description 5
- 231100000719 pollutant Toxicity 0.000 claims description 5
- ZZVUWRFHKOJYTH-FIBGUPNXSA-N 2-benzhydryloxy-N-methyl-N-(trideuteriomethyl)ethanamine Chemical compound C=1C=CC=CC=1C(OCCN(C)C([2H])([2H])[2H])C1=CC=CC=C1 ZZVUWRFHKOJYTH-FIBGUPNXSA-N 0.000 claims description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 4
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 239000012299 nitrogen atmosphere Substances 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- 230000003213 activating effect Effects 0.000 claims 1
- 230000001387 anti-histamine Effects 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 abstract description 4
- 208000026935 allergic disease Diseases 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 4
- 229940124623 antihistamine drug Drugs 0.000 abstract description 3
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 abstract description 3
- 230000004044 response Effects 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 18
- 238000011084 recovery Methods 0.000 description 14
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 6
- 239000013076 target substance Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000012086 standard solution Substances 0.000 description 4
- 238000007664 blowing Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008239 natural water Substances 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 239000010865 sewage Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 239000012496 blank sample Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 231100001240 inorganic pollutant Toxicity 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000002957 persistent organic pollutant Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000016160 smooth muscle contraction Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/08—Preparation using an enricher
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
本发明公开了一种水体中抗组胺类药物的快速检测分析方法,能用于治疗过敏性疾病药物的检测,利用固相萃取小柱结合高效液相色谱—质谱方法,能够高效、快速的同时检测水体中6种抗组胺类药物,包括西咪替丁、苯海拉明、西替利嗪、非索非那定、氯苯那敏、雷尼替丁。该方法包括以下步骤:先将水样过滤,并加入内标物;再使用固相萃取小柱提取、净化样品中的6种他汀类物质;再通过高效液相色谱—质谱仪检测水样中目标物的含量。本发明对水样的处理步骤简单,操作方便,稳定性好,能够快速得到适于液质联用仪检测的样品;样品预处理成本低,利用实验室常见的耗材就能完成,检测速度快,自动化程度高,响应灵敏,适于推广应用。
The invention discloses a rapid detection and analysis method for antihistamine drugs in water, which can be used for the detection of drugs for treating allergic diseases. At the same time, 6 kinds of antihistamines were detected in water, including cimetidine, diphenhydramine, cetirizine, fexofenadine, chlorpheniramine, and ranitidine. The method includes the following steps: firstly filter the water sample and add internal standard substance; then use a solid phase extraction cartridge to extract and purify 6 kinds of statins in the sample; and then detect the water sample by high performance liquid chromatography-mass spectrometer target content. The invention has simple processing steps for water samples, convenient operation and good stability, and can quickly obtain samples suitable for detection by liquid mass spectrometer; the sample pretreatment cost is low, can be completed by using common consumables in laboratories, and the detection speed is fast , high degree of automation, sensitive response, suitable for popularization and application.
Description
技术领域technical field
本发明涉及一种用于治疗过敏性疾病药物的检测方法,特别是涉及一种抗组胺类药物的检测分析方法,应用于水体中有机污染物痕量检测技术领域。The invention relates to a detection method for drugs for treating allergic diseases, in particular to a detection and analysis method for antihistamine drugs, which is applied to the technical field of trace detection of organic pollutants in water bodies.
背景技术Background technique
随着现代医学的进步和发展,每一年在世界范围内由于预防、治疗人类和动物疾病而产生和消耗大量的药物。这些药物会通过多种途径进入自然水体和水域。最常见的方式是制药厂附近的工业污水排放和人类及动物机体代谢而导致的生活污水排放。经过先关文献调研,目前已经检测到污水和环境中存在着一定浓度的药物及其代谢产物,虽然其浓度水平比规定的人类及动物的毒性风险浓度要低几个数量级,但它们对环境的长期影响仍不容忽视。With the progress and development of modern medicine, a large number of drugs are produced and consumed every year in the world for the prevention and treatment of human and animal diseases. These drugs enter natural water bodies and water bodies through a variety of routes. The most common way is the discharge of industrial sewage near pharmaceutical factories and the discharge of domestic sewage caused by the metabolism of human and animal bodies. After the previous literature research, it has been detected that there are certain concentrations of drugs and their metabolites in sewage and the environment. Although their concentration levels are several orders of magnitude lower than the specified toxic risk concentrations for humans and animals, their effects on the environment The long-term impact cannot be ignored.
抗组胺药作为常见的一大类药物,具体作用是拮抗组胺对人体的生物效应,进而避免组胺引起的毛细血管扩张及通透性增加、平滑肌痉挛、分泌活动增强而导致的局部充血、水肿、分泌物增多、支气管和消化道平滑肌收缩等临床症状。抗组胺药由于制作容易,价格便宜,给药方便,且对多种变态反应病有效,所以临床用途广泛。As a common class of drugs, antihistamines specifically function to antagonize the biological effects of histamine on the human body, thereby avoiding local congestion caused by histamine-induced telangiectasia and increased permeability, smooth muscle spasm, and enhanced secretion activity. , edema, increased secretions, bronchial and digestive tract smooth muscle contraction and other clinical symptoms. Antihistamines are widely used in clinical practice due to their easy preparation, low price, convenient administration, and effectiveness against various allergic diseases.
抗组胺药会通过各种途径不断释放进入水体,由于去除效率差,即使是饮用水处理厂处理后的水中也会有他汀类药物的存在,将对人和生物有不利影响。由于水样成分复杂,含有有机和无机污染物质,这些物质的存在对准确快速的检测干扰较大,对样品的净化富集水平要求较高。目前针对水体样品的预处理方法主要是液液萃取、玻璃棒萃取法,存在耗费较多的提取溶剂,实验所需时间较长,步骤复杂等问题。这成为亟待了解决的技术问题。Antihistamines are continuously released into water bodies through various channels. Due to the poor removal efficiency, even the water treated by drinking water treatment plants will contain statins, which will adversely affect humans and organisms. Due to the complex composition of water samples and the presence of organic and inorganic pollutants, the existence of these substances greatly interferes with accurate and rapid detection, and requires high levels of purification and enrichment of samples. At present, the pretreatment methods for water samples are mainly liquid-liquid extraction and glass rod extraction, which consume a lot of extraction solvent, require a long time for experiments, and have complicated steps. This has become an urgent technical problem to be solved.
发明内容SUMMARY OF THE INVENTION
为了解决现有技术问题,本发明的目的在于克服已有技术存在的不足,提供一种水体中抗组胺类药物的快速检测分析方法,能对环境水体进行预处理,以改善现有处理方法的过程复杂,且成本较高的技术问题。同时,本发明采用抗组胺类药物的高效液相色谱—质谱的检测方法,该检测方法能够同时检测6种他汀类药物物质,包括西咪替丁、苯海拉明、西替利嗪、非索非那定、氯苯那敏、雷尼替丁,检测过程快速、高效、低成本、高度自动化且便于产业化应用。In order to solve the problems of the prior art, the purpose of the present invention is to overcome the deficiencies of the prior art, and to provide a rapid detection and analysis method for antihistamines in water bodies, which can pretreat environmental water bodies to improve the existing treatment methods. The process is complicated and the cost is high. At the same time, the present invention adopts a high-performance liquid chromatography-mass spectrometry detection method for antihistamine drugs, and the detection method can simultaneously detect 6 kinds of statin drug substances, including cimetidine, diphenhydramine, cetirizine, Fexofenadine, chlorpheniramine, ranitidine, the detection process is fast, efficient, low-cost, highly automated and easy for industrial application.
为达到上述发明创造目的,本发明采用如下技术方案:In order to achieve the above-mentioned purpose of invention and creation, the present invention adopts the following technical solutions:
一种水体中抗组胺类药物的快速检测分析方法,包括如下步骤:A method for rapid detection and analysis of antihistamines in water, comprising the following steps:
a.样品的预处理:a. Pretreatment of samples:
在水体样本中加入内标物西替利嗪-d8和苯海拉明-d3混匀;Add internal standard cetirizine-d8 and diphenhydramine-d3 to water samples and mix well;
b.使用固相萃取柱进行富集净化:b. Use solid phase extraction column for enrichment and purification:
过柱的具体流程为:首先将固相萃取柱用不超过6mL的超纯水或甲醇进行活化,其次将过滤后的200mL水样以2ml/min的速度通过色谱柱,随后用不超过5mL超纯水以1~3mL/min的流速淋洗,然后在0.6bar的气压下干燥至少30min,最后用不超过6ml甲醇洗脱;在40℃的氮气氛围中吹至近干后,用1mL甲醇定容,随后转移到高效液相色谱瓶中用于检测;The specific process of passing the column is as follows: firstly, activate the solid-phase extraction column with ultrapure water or methanol of no more than 6mL, and then pass the filtered 200mL water sample through the chromatographic column at a speed of 2ml/min, and then use no more than 5mL ultrapure water to pass through the column. Rinse with pure water at a flow rate of 1 to 3 mL/min, then dry at a pressure of 0.6 bar for at least 30 min, and finally elute with no more than 6 mL of methanol; after blowing to near dryness in a nitrogen atmosphere at 40 °C, use 1 mL of methanol to dilute to volume , and then transferred to HPLC vials for detection;
c.高效液相色谱—质谱联用仪测定样品中目标物的含量:c. Determination of the content of the target substance in the sample by high performance liquid chromatography-mass spectrometry:
建立目标污染物的标准曲线,以浓度为横坐标,以峰面积为纵坐标;采用内标法,在高效液相色谱—质谱联用仪上定量检测水样中提取到的目标物的浓度。A standard curve of the target pollutants was established, with the concentration as the abscissa and the peak area as the ordinate; the internal standard method was used to quantitatively detect the concentration of the target compounds extracted from the water samples on a high performance liquid chromatography-mass spectrometer.
作为本发明优选的技术方案,在所述步骤a中,将样品粗滤至少三次,细滤至少三次;每250mL的水体样本中添加内标物的总浓度为20~100ppb。As a preferred technical solution of the present invention, in the step a, the sample is roughly filtered at least three times and finely filtered at least three times; the total concentration of the internal standard added in each 250 mL of water sample is 20-100 ppb.
作为本发明优选的技术方案,在所述步骤b中,在进行氮气吹干的过程为45~60min。As a preferred technical solution of the present invention, in the step b, the process of drying with nitrogen is 45-60 min.
作为本发明优选的技术方案,在所述步骤c中,高效液相色谱—质谱仪的检测条件为:As a preferred technical solution of the present invention, in the step c, the detection conditions of the high performance liquid chromatography-mass spectrometer are:
柱温为35℃,进样体积为3μL,流速为0.3mL/min;The column temperature was 35 °C, the injection volume was 3 μL, and the flow rate was 0.3 mL/min;
流动相采用HPLC级甲酸铵-甲酸溶液(A)和甲酸的乙腈溶液(B),其中HPLC级甲酸铵-甲酸溶液(A)中的甲酸铵浓度为0.1mol/L,HPLC级甲酸铵-甲酸溶液(A)的pH为3.5,甲酸的乙腈溶液(B)中甲酸浓度为0.1mol/L;梯度(wt.%A)如下:0min,95%;1min,95%;3min,80%;5min,80%;5.01min,65%;9min,55%;9.01min,0%;11min,0%;11.0min,95%;12min,95%;The mobile phase adopts HPLC grade ammonium formate-formic acid solution (A) and acetonitrile solution of formic acid (B), wherein the ammonium formate concentration in the HPLC grade ammonium formate-formic acid solution (A) is 0.1mol/L, and the HPLC grade ammonium formate-formic acid The pH of the solution (A) is 3.5, and the formic acid concentration in the formic acid in acetonitrile solution (B) is 0.1 mol/L; the gradient (wt.% A) is as follows: 0min, 95%; 1min, 95%; 3min, 80%; 5min , 80%; 5.01min, 65%; 9min, 55%; 9.01min, 0%; 11min, 0%; 11.0min, 95%; 12min, 95%;
干燥气体流量:8L/min,干燥气体温度:300℃,鞘气体温度:350℃,鞘层气体流量:11L/min,雾化器压力:60psi,喷嘴电压(-):1500V,喷嘴电压(+):1500V,毛细管电压(-):4500。Drying gas flow rate: 8L/min, drying gas temperature: 300℃, sheath gas temperature: 350℃, sheath gas flow rate: 11L/min, atomizer pressure: 60psi, nozzle voltage (-): 1500V, nozzle voltage (+ ): 1500V, capillary voltage (-): 4500.
作为本发明优选的技术方案,在所述步骤c中,对水体样本中西咪替丁、苯海拉明、西替利嗪、非索非那定、氯苯那敏、雷尼替丁进行浓度检测。As a preferred technical solution of the present invention, in the step c, the concentration of cimetidine, diphenhydramine, cetirizine, fexofenadine, chlorpheniramine and ranitidine in the water sample is carried out. detection.
本发明与现有技术相比较,具有如下显而易见的突出实质性特点和显著优点:Compared with the prior art, the present invention has the following obvious outstanding substantive features and significant advantages:
1.本发明建立了滤膜过滤与固相萃取串联的前处理方法,再使用固相萃取小柱串联高效液相色谱质谱方法,在一级质谱和二级质谱的模式下分别进行扫描,具有的稳定性高、重复性好、结果准确的优势;1. The present invention establishes a pretreatment method of membrane filtration and solid-phase extraction in series, and then uses a solid-phase extraction small column in series with a high-performance liquid chromatography mass spectrometry method to scan under the modes of primary mass spectrometry and secondary mass spectrometry, respectively. The advantages of high stability, good repeatability and accurate results;
2.本发明前处理方法简单,操作易行,并且所选用的仪器测量的分辨率好,准确性高,多级扫描后增强该方法的灵敏度和可信度,数据分析与处理的结果呈现简单明了,定性分析综合全面,可以实现全面筛选非目标性的污染物这一功能;2. The pretreatment method of the present invention is simple, easy to operate, and the selected instrument has good resolution and high accuracy. After multi-level scanning, the sensitivity and reliability of the method are enhanced, and the results of data analysis and processing are simple to present. It is clear that the qualitative analysis is comprehensive and comprehensive, and the function of comprehensive screening of non-target pollutants can be realized;
3.本发明方法日内精密度和日间精密度均满足要求,相对标准偏差(RSDs)分别小于9.8%。方法精密度较好,重复性高,结果准确灵敏、可靠,适用范围广。3. The intra-day precision and inter-day precision of the method of the present invention both meet the requirements, and the relative standard deviations (RSDs) are respectively less than 9.8%. The method has good precision, high repeatability, accurate, sensitive, and reliable results, and has a wide range of applications.
附图说明Description of drawings
图1是本发明实施例二方法检测的六种抗组胺药的色谱图。Fig. 1 is the chromatogram of six kinds of antihistamines detected by the method of the second embodiment of the present invention.
具体实施方式Detailed ways
以下结合具体的实施例子对上述方案做进一步说明,本发明的优选实施例详述如下:The above scheme will be further described below in conjunction with specific embodiments, and preferred embodiments of the present invention are described in detail as follows:
实施例一:Example 1:
在本实施例中,一种水体中抗组胺类药物的快速检测分析方法,加标回收率实验,采用内标法检测自然水体中抗组胺药的回收率,包括如下步骤:In the present embodiment, a method for rapid detection and analysis of antihistamines in water, the standard addition recovery experiment, using the internal standard method to detect the recovery of antihistamines in natural water, includes the following steps:
a.样品的预处理:a. Pretreatment of samples:
将水体样本粗滤三次,细滤三次;设立三组平行样,每组水样取250ml,在每组水样中添加浓度为20ppb的西替利嗪-d8和苯海拉明-d3溶液总计1mL,混合混匀;The water samples were coarsely filtered three times and finely filtered three times; three groups of parallel samples were set up, each group of water samples was taken 250ml, and the total concentration of 20ppb of cetirizine-d8 and diphenhydramine-d3 solutions was added to each group of water samples. 1mL, mix well;
b.使用固相萃取柱进行富集净化:b. Use solid phase extraction column for enrichment and purification:
过柱的具体流程为:首先将固相萃取柱用5mL的甲醇进行活化,其次将过滤后的200mL水样以2ml/min的速度通过色谱柱,随后用5mL超纯水以3mL/min的流速淋洗,然后在0.6bar的气压下干燥30min,最后用3ml甲醇洗脱;在40℃的氮气氛围中吹至近干后,用1mL甲醇定容,随后转移到高效液相色谱瓶中用于检测;The specific process of passing the column is: firstly activate the solid-phase extraction column with 5mL of methanol, secondly pass the filtered 200mL water sample through the chromatographic column at a speed of 2ml/min, and then use 5mL of ultrapure water at a flow rate of 3mL/min. Rinse, then dry at 0.6 bar for 30 min, and finally elute with 3 ml of methanol; after blowing to near dryness in a nitrogen atmosphere at 40 °C, make up to volume with 1 mL of methanol, and then transfer to a high performance liquid chromatography bottle for detection ;
c.高效液相色谱—质谱联用仪测定样品中目标物的含量:c. Determination of the content of the target substance in the sample by high performance liquid chromatography-mass spectrometry:
建立目标污染物的标准曲线,以浓度为横坐标,以峰面积为纵坐标;采用内标法,在高效液相色谱—质谱联用仪上定量检测水样中提取到的目标物的浓度。A standard curve of the target pollutants was established, with the concentration as the abscissa and the peak area as the ordinate; the internal standard method was used to quantitatively detect the concentration of the target compounds extracted from the water samples on a high performance liquid chromatography-mass spectrometer.
高效液相色谱—质谱仪的检测条件为:The detection conditions of high performance liquid chromatography-mass spectrometer are:
柱温为35℃,进样体积为3μL,流速为0.3mL/min;The column temperature was 35 °C, the injection volume was 3 μL, and the flow rate was 0.3 mL/min;
流动相采用HPLC级甲酸铵-甲酸溶液(A)和甲酸的乙腈溶液(B),其中HPLC级甲酸铵-甲酸溶液(A)中的甲酸铵浓度为0.1mol/L,HPLC级甲酸铵-甲酸溶液(A)的pH为3.5,甲酸的乙腈溶液(B)中甲酸浓度为0.1mol/L;梯度(wt.%A)如下:0min,95%;1min,95%;3min,80%;5min,80%;5.01min,65%;9min,55%;9.01min,0%;11min,0%;11.0min,95%;12min,95%;The mobile phase adopts HPLC grade ammonium formate-formic acid solution (A) and acetonitrile solution of formic acid (B), wherein the ammonium formate concentration in the HPLC grade ammonium formate-formic acid solution (A) is 0.1mol/L, and the HPLC grade ammonium formate-formic acid The pH of the solution (A) is 3.5, and the formic acid concentration in the formic acid in acetonitrile solution (B) is 0.1 mol/L; the gradient (wt.% A) is as follows: 0min, 95%; 1min, 95%; 3min, 80%; 5min , 80%; 5.01min, 65%; 9min, 55%; 9.01min, 0%; 11min, 0%; 11.0min, 95%; 12min, 95%;
干燥气体流量:8L/min,干燥气体温度:300℃,鞘气体温度:350℃,鞘层气体流量:11L/min,雾化器压力:60psi,喷嘴电压(-):1500V,喷嘴电压(+):1500V,毛细管电压(-):4500。Drying gas flow rate: 8L/min, drying gas temperature: 300℃, sheath gas temperature: 350℃, sheath gas flow rate: 11L/min, atomizer pressure: 60psi, nozzle voltage (-): 1500V, nozzle voltage (+ ): 1500V, capillary voltage (-): 4500.
实验测试分析:Experimental test analysis:
在本实施例中,采用加标回收率计算。加标回收率的计算公式为:RE%=(C2V2-C1V1)/C0V0其中:RE:加标回收率,%;C0:混合标准液的浓度,ng/mL;V0:混合标准液的体积,mL;C1:空白样品的检测浓度,ng/mL;V1:空白样品定容时的体积,mL;C2:加入混合标准液的样品的检测浓度ng/mL;V2:加入混合标准液的样品定容时的体积,mL。In this embodiment, the standard addition recovery rate is used for calculation. The calculation formula of the recovery rate of standard addition is: RE%=(C 2 V 2 -C 1 V 1 )/C 0 V 0 where: RE: recovery rate of standard addition, %; C 0 : concentration of mixed standard solution, ng/ mL; V 0 : volume of mixed standard solution, mL; C 1 : detection concentration of blank sample, ng/mL; V 1 : volume of blank sample at constant volume, mL; C 2 : detection of sample added with mixed standard solution Concentration ng/mL; V 2 : the volume of the sample added to the mixed standard solution at constant volume, mL.
本实施例实测结果为58.56μg/L,加标回收率为79.62%,相对标准偏差(n=3)为4.98。由此可见,本方法检测准确性较好。The measured result in this example is 58.56 μg/L, the recovery rate of standard addition is 79.62%, and the relative standard deviation (n=3) is 4.98. It can be seen that the detection accuracy of this method is better.
通过加标回收率实验可以对检验结果进行校正,排除人为操作误差,降低基质干扰效应。本发明采用的固相小柱萃取方法,可有效分离待测组分与样品基质,克服基质效应,实验结果重现性好,回收率高,检测结果准确。The test results can be corrected through the standard addition recovery experiment to eliminate human error and reduce the effect of matrix interference. The solid-phase small column extraction method adopted in the present invention can effectively separate the components to be tested and the sample matrix, overcome the matrix effect, have good reproducibility of experimental results, high recovery rate and accurate detection results.
实施例二:Embodiment 2:
本实施例与实施例一基本相同,特别之处在于:This embodiment is basically the same as the first embodiment, and the special features are:
本实施例进行实际样品中抗组胺药浓度的测定,随机收集环境中水样5份,使用实施例一的步骤a的方法进行预处理,再使用实施例一的步骤b的固相萃取方法进行净化与富集,之后采用实施例一的步骤c的高效液相色谱—质谱的方法对样品中目标物的实际浓度进行分析检测。具体检测过程如下:In this example, the concentration of antihistamines in actual samples is measured, and 5 water samples in the environment are randomly collected, pretreated with the method of step a of Example 1, and then the solid phase extraction method of step b of Example 1 is used. Purification and enrichment are carried out, and then the method of high performance liquid chromatography-mass spectrometry in step c of Example 1 is used to analyze and detect the actual concentration of the target substance in the sample. The specific detection process is as follows:
在本实施例中,一种水体中抗组胺类药物的快速检测分析方法,加标回收率实验,采用内标法检测自然水体中抗组胺药的回收率,包括如下步骤:In the present embodiment, a method for rapid detection and analysis of antihistamines in water, the standard addition recovery experiment, using the internal standard method to detect the recovery of antihistamines in natural water, includes the following steps:
a.样品的预处理:a. Pretreatment of samples:
将水体样本粗滤三次,细滤三次;设立三组平行样,每组水样取250ml,在每组水样中添加浓度为20ppb的西替利嗪-d8和苯海拉明-d3溶液总计1mL,混合混匀;The water samples were coarsely filtered three times and finely filtered three times; three groups of parallel samples were set up, each group of water samples was taken 250ml, and the total concentration of 20ppb of cetirizine-d8 and diphenhydramine-d3 solutions was added to each group of water samples. 1mL, mix well;
b.使用固相萃取柱进行富集净化:b. Use solid phase extraction column for enrichment and purification:
过柱的具体流程为:首先将固相萃取柱用5mL的甲醇进行活化,其次将过滤后的200mL水样以2ml/min的速度通过色谱柱,随后用5mL超纯水以3mL/min的流速淋洗,然后在0.6bar的气压下干燥30min,最后用3ml甲醇洗脱;在40℃的氮气氛围中吹至近干后,用1mL甲醇定容,随后转移到高效液相色谱瓶中用于检测;The specific process of passing the column is: firstly activate the solid-phase extraction column with 5mL of methanol, secondly pass the filtered 200mL water sample through the chromatographic column at a speed of 2ml/min, and then use 5mL of ultrapure water at a flow rate of 3mL/min. Rinse, then dry at 0.6 bar for 30 min, and finally elute with 3 ml of methanol; after blowing to near dryness in a nitrogen atmosphere at 40 °C, make up to volume with 1 mL of methanol, and then transfer to a high performance liquid chromatography bottle for detection ;
c.高效液相色谱—质谱联用仪测定样品中目标物的含量:c. Determination of the content of the target substance in the sample by high performance liquid chromatography-mass spectrometry:
建立目标污染物的标准曲线,以浓度为横坐标,以峰面积为纵坐标;采用内标法,在高效液相色谱—质谱联用仪上定量检测水样中提取到的目标物的浓度。A standard curve of the target pollutants was established, with the concentration as the abscissa and the peak area as the ordinate; the internal standard method was used to quantitatively detect the concentration of the target compounds extracted from the water samples on a high performance liquid chromatography-mass spectrometer.
高效液相色谱—质谱仪的检测条件为:The detection conditions of high performance liquid chromatography-mass spectrometer are:
柱温为35℃,进样体积为3μL,流速为0.3mL/min;The column temperature was 35 °C, the injection volume was 3 μL, and the flow rate was 0.3 mL/min;
流动相采用HPLC级甲酸铵-甲酸溶液(A)和甲酸的乙腈溶液(B),其中HPLC级甲酸铵-甲酸溶液(A)中的甲酸铵浓度为0.1mol/L,HPLC级甲酸铵-甲酸溶液(A)的pH为3.5,甲酸的乙腈溶液(B)中甲酸浓度为0.1mol/L;梯度(wt.%A)如下:0min,95%;1min,95%;3min,80%;5min,80%;5.01min,65%;9min,55%;9.01min,0%;11min,0%;11.0min,95%;12min,95%;The mobile phase adopts HPLC grade ammonium formate-formic acid solution (A) and acetonitrile solution of formic acid (B), wherein the ammonium formate concentration in the HPLC grade ammonium formate-formic acid solution (A) is 0.1mol/L, and the HPLC grade ammonium formate-formic acid The pH of the solution (A) is 3.5, and the formic acid concentration in the formic acid in acetonitrile solution (B) is 0.1 mol/L; the gradient (wt.% A) is as follows: 0min, 95%; 1min, 95%; 3min, 80%; 5min , 80%; 5.01min, 65%; 9min, 55%; 9.01min, 0%; 11min, 0%; 11.0min, 95%; 12min, 95%;
干燥气体流量:8L/min,干燥气体温度:300℃,鞘气体温度:350℃,鞘层气体流量:11L/min,雾化器压力:60psi,喷嘴电压(-):1500V,喷嘴电压(+):1500V,毛细管电压(-):4500。Drying gas flow rate: 8L/min, drying gas temperature: 300℃, sheath gas temperature: 350℃, sheath gas flow rate: 11L/min, atomizer pressure: 60psi, nozzle voltage (-): 1500V, nozzle voltage (+ ): 1500V, capillary voltage (-): 4500.
实验测试分析:Experimental test analysis:
本实施例检测得到5份水样中的抗组胺药类药物浓度如下表1所示。实验结果说明本实施例方法可以应用于环境水样中抗组胺药类药物的测定。The concentrations of antihistamines in the 5 water samples detected in this example are shown in Table 1 below. The experimental results show that the method of this embodiment can be applied to the determination of antihistamines in environmental water samples.
表1.水体样本中6种抗组胺药类药物的浓度检测结果Table 1. Concentration test results of 6 antihistamines in water samples
本实施例步骤b中固相萃取小柱是Waters公司Oasis HLB型小柱。本实施例步骤c中高效液相色谱—质谱仪型号为SCIEX QTRAP 5500型液相色谱仪,色谱柱为Kinetex120EC-C18反相柱(3×100mm,2.7μm,phenomenex)。本实施例利用固相萃取小柱结合高效液相色谱—质谱技术,能够高效、快速的同时检测水体中6种抗组胺类药物,包括西咪替丁、苯海拉明、西替利嗪、非索非那定、氯苯那敏、雷尼替丁等。图1为本实施例方法检测的六种抗组胺药的色谱图。由图1可知,采用本方法获得的抗组胺药的色谱图峰形优美,且分离效果较好,各类药物信号强度很高,均在10e5以上。表1为本实施例采用的固相小柱萃取方法的效果,本方法对五份水样中的六种抗组胺药进行回收率测试,其回收率均在80%以上,显示较高的回收率,表明该方法可有效分离待测组分与样品基质,保可证检测结果准确。The solid-phase extraction cartridge in step b of this example is an Oasis HLB-type cartridge from Waters. In step c of this example, the model of the high-performance liquid chromatography-mass spectrometer is a SCIEX QTRAP 5500 liquid chromatograph, and the chromatographic column is a Kinetex120EC-C18 reversed-phase column (3×100 mm, 2.7 μm, phenomenex). This embodiment utilizes solid phase extraction cartridges combined with high performance liquid chromatography-mass spectrometry technology to efficiently and rapidly detect 6 kinds of antihistamines in water, including cimetidine, diphenhydramine, and cetirizine. , Fexofenadine, Chlorpheniramine, Ranitidine, etc. Fig. 1 is the chromatogram of six kinds of antihistamines detected by the method of this embodiment. It can be seen from Figure 1 that the chromatographic peaks of the antihistamines obtained by this method are beautiful, and the separation effect is good, and the signal intensities of various drugs are very high, all above 10e5. Table 1 shows the effects of the solid-phase small column extraction method used in this example. The method tests the recovery rates of six antihistamines in five water samples, and the recovery rates are all above 80%, showing a higher The recovery rate shows that the method can effectively separate the components to be tested and the sample matrix, and ensure accurate detection results.
综上所述,本发明上述实施例用于治疗过敏性疾病药物的检测方法,利用固相萃取小柱结合高效液相色谱—质谱技术,能够高效、快速的同时检测水体中6种抗组胺类药物,包括西咪替丁、苯海拉明、西替利嗪、非索非那定、氯苯那敏、雷尼替丁。该方法包括以下步骤:(1)将水样过滤,并加入内标物;(2)使用固相萃取小柱提取、净化样品中的6种他汀类物质;(3)通过高效液相色谱—质谱仪检测水样中目标物的含量。本发明对水样的处理步骤简单,操作方便,稳定性好,能够快速得到适于液质联用仪检测的样品;样品预处理成本低,利用实验室常见的耗材就能完成,能在各类前处理实验室完成。此方法能够同时对6种抗组胺类药物进行快速高效地检测,检测速度快,自动化程度高,响应灵敏,回收率能达到70.62-110.37%之间,便于产业化应用,是一种简便、快捷、准确的定性定量检测方法,适于推广应用。To sum up, the above embodiments of the present invention are used for the detection method of drugs for the treatment of allergic diseases, using solid phase extraction cartridges combined with high performance liquid chromatography-mass spectrometry technology, can efficiently and rapidly detect 6 kinds of antihistamines in water bodies at the same time. Class of drugs, including cimetidine, diphenhydramine, cetirizine, fexofenadine, chlorpheniramine, ranitidine. The method comprises the following steps: (1) filtering the water sample and adding an internal standard substance; (2) extracting and purifying 6 kinds of statins in the sample by using a solid phase extraction cartridge; (3) passing the high performance liquid chromatography- The mass spectrometer detects the content of the target substance in the water sample. The invention has the advantages of simple processing steps for water samples, convenient operation and good stability, and can quickly obtain samples suitable for detection by liquid mass spectrometer; the sample pretreatment cost is low, can be completed by using common consumables in the laboratory, and can be used in various laboratories. The pre-class processing lab is completed. This method can simultaneously detect 6 kinds of antihistamines quickly and efficiently, with fast detection speed, high degree of automation, sensitive response, and the recovery rate can reach 70.62-110.37%, which is convenient for industrial application. Fast and accurate qualitative and quantitative detection method, suitable for popularization and application.
上面对本发明实施例结合附图进行了说明,但本发明不限于上述实施例,还可以根据本发明的发明创造的目的做出多种变化,凡依据本发明技术方案的精神实质和原理下做的改变、修饰、替代、组合或简化,均应为等效的置换方式,只要符合本发明的发明目的,只要不背离本发明水体中抗组胺类药物的快速检测分析方法的技术原理和发明构思,都属于本发明的保护范围。The embodiments of the present invention have been described above in conjunction with the accompanying drawings, but the present invention is not limited to the above-mentioned embodiments, and various changes can also be made according to the purpose of the invention and creation of the present invention. The changes, modifications, substitutions, combinations or simplifications should be equivalent substitution methods, as long as they meet the purpose of the invention, as long as they do not deviate from the technical principles and inventions of the rapid detection and analysis method for antihistamines in water of the invention All ideas belong to the protection scope of the present invention.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010385171.6A CN111551658B (en) | 2020-05-09 | 2020-05-09 | Rapid detection and analysis method of antihistamines in water |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010385171.6A CN111551658B (en) | 2020-05-09 | 2020-05-09 | Rapid detection and analysis method of antihistamines in water |
Publications (2)
Publication Number | Publication Date |
---|---|
CN111551658A true CN111551658A (en) | 2020-08-18 |
CN111551658B CN111551658B (en) | 2022-12-23 |
Family
ID=72001525
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010385171.6A Active CN111551658B (en) | 2020-05-09 | 2020-05-09 | Rapid detection and analysis method of antihistamines in water |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111551658B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115047104A (en) * | 2022-06-14 | 2022-09-13 | 重庆市食品药品检验检测研究院 | Method for rapidly detecting illegal addition of 36 antihistamines in cosmetics |
CN116953128A (en) * | 2023-09-19 | 2023-10-27 | 北京师范大学 | Analysis method, device and system for common antipyretic, antitussive and pharyngitis treatment medicine components in water body |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103308642A (en) * | 2013-06-28 | 2013-09-18 | 南京大学 | High performance liquid chromatography-flight time mass spectrum combination method for simultaneously and rapidly screening and identifying antihistamine medicines in water samples |
CN108872427A (en) * | 2018-06-28 | 2018-11-23 | 浙江公正检验中心有限公司 | The detection method of 15 kinds of Loratadines in animal derived food |
-
2020
- 2020-05-09 CN CN202010385171.6A patent/CN111551658B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103308642A (en) * | 2013-06-28 | 2013-09-18 | 南京大学 | High performance liquid chromatography-flight time mass spectrum combination method for simultaneously and rapidly screening and identifying antihistamine medicines in water samples |
CN108872427A (en) * | 2018-06-28 | 2018-11-23 | 浙江公正检验中心有限公司 | The detection method of 15 kinds of Loratadines in animal derived food |
Non-Patent Citations (5)
Title |
---|
JOHN L. WILKINSON ET AL: "A Novel Method to Characterise Levels of Pharmaceutical Pollution in Large-Scale Aquatic Monitoring Campaigns", 《APPLIED SCIENCES》 * |
JUSSI KOSONEN ET AL: "The occurrence of antihistamines in sewage waters and in recipient rivers", 《ENVIRON SCI POLLUT RES》 * |
KATHRYN PROCTOR ET AL: "Multi-residue ultra-performance liquid chromatography coupled with tandem mass spectrometry method for comprehensive multi-class anthropogenic compounds of emerging concern analysis in a catchment-based exposure-driven study", 《ANALYTICAL AND BIOANALYTICAL CHEMISTRY》 * |
RENÁTA VARGA ET AL: "Determination of antihypertensive and anti-ulcer agents from surface water with solid-phase extraction–liquid chromatography–electrospray ionization tandem mass spectrometry", 《TALANTA》 * |
陈永艳 等: "超高效液相色谱串联质谱测定饮用水中PPCPs残留", 《中国给水排水》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115047104A (en) * | 2022-06-14 | 2022-09-13 | 重庆市食品药品检验检测研究院 | Method for rapidly detecting illegal addition of 36 antihistamines in cosmetics |
CN116953128A (en) * | 2023-09-19 | 2023-10-27 | 北京师范大学 | Analysis method, device and system for common antipyretic, antitussive and pharyngitis treatment medicine components in water body |
CN116953128B (en) * | 2023-09-19 | 2023-12-08 | 北京师范大学 | Analysis methods, devices and systems for components of commonly used antipyretic, cough relieving and pharyngitis treatment drugs in water bodies |
Also Published As
Publication number | Publication date |
---|---|
CN111551658B (en) | 2022-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105424825B (en) | A kind of method that separation and concentration determines 12 kinds of left drugs in water environment | |
CN107543877A (en) | A kind of method that SPE liquid chromatography tandem mass spectrometry determines six 24 kinds of antibiotic of class in water body simultaneously | |
CN105651922B (en) | Method for determining PPCPs in environmental water sample | |
CN105241990A (en) | Method for determining 10 kinds of antibiotics in water environment through combination of sample pre-treatment technology and HPLC-MS | |
CN103323550A (en) | Method for simultaneously detecting five medicaments in water | |
CN111551658A (en) | Rapid detection and analysis method of antihistamines in water | |
CN104297406A (en) | Method for broad spectrum identification of beta-receptor stimulant medicines | |
CN103399096A (en) | Method for detecting content of malachite green and metabolin thereof in sediment of aquaculture environment | |
CN103293248A (en) | Method for separating and enriching sulfanilamide antibiotics in water | |
CN105259287A (en) | Second-order mass spectrometric detection method for bisphenol substances in water environment | |
CN110133131A (en) | Rapid detection and analysis method of statins in water | |
CN109358123A (en) | A method for simultaneous detection of multiple psychoactive drugs in water | |
CN111551659B (en) | Rapid detection and analysis method for anti-cancer drugs in sludge of sewage treatment plant | |
CN108760952A (en) | Method for detecting non-steroidal anti-inflammatory drugs in water | |
CN103512983A (en) | High performance liquid chromatography determining method for caffeine in coffee and product thereof | |
CN117347532B (en) | HPLC characteristic spectrum detection method for Guizhi sugar-cellulitis granule preparation | |
CN109725095A (en) | A kind of method that adopts HPLC to simultaneously detect the content of various biogenic amines in soy sauce | |
CN111665315B (en) | Detection and analysis method of anticancer drugs in natural water body | |
CN111707744A (en) | Instrument and method for simultaneous characterization of physicochemical/optical properties of organic matter to be measured | |
CN113671093A (en) | Method for rapid detection of parabens in human urine | |
CN103336080A (en) | Method for simultaneously detecting tetracycline antibiotics in water | |
CN1546991A (en) | Determination method of trace microcystin in water | |
CN105987965A (en) | Method for determining various types of abuse drugs in human whole blood | |
CN113552274B (en) | Method for establishing high-performance liquid phase fingerprint spectrum of artemisinin by-product and measuring content of artemisinin by-product | |
CN110398542B (en) | Detection and analysis method of benzophenones in human urine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |